MyotonicUK began grantmaking activities in 2015. MyotonicUK has formed an alliance with Myotonic in the United States to support selected basic and translational research projects, as a component of its efforts to accelerate therapy development. Information on Myotonic is available here

MyotonicUK grant recipients include:

Research Grant Awards

  • The University of Utah, Primary Investigator Nicholas Johnson, M.D.: Population-based Prevalence Study in Myotonic Dystrophy Type-1 and Type-2
  • The Jackson Laboratory, Primary Investigator Cathleen Lutz, Ph.D.: Building a Better Mouse
  • Massachusetts General Hospital, Primary Investigator Thurman Wheeler, M.D.: Extracellular RNA as Biomarkers of Myotonic Dystrophy
  • RUCDR Infinite Biologics, Rutgers University, Primary Investigator Michael Sheldon, Ph.D.: DM Cell Line Library
  • University of Florida, Primary Investigator Donovan Lott, D.PT.: Development of Magnetic Resonance Imaging as an Endpoint in Myotonic Dystrophy Type 1
  • Newcastle University, Primary Investigator Hanns Lochmuller, Ph.D., PHENO-DM1 - DM1 Deep Phenotyping to Improve Delivery of Personalized Medicine and Assist in the Planning, Design and Recruitment of Clinical Trials
  • University of Florida - Icagen, Inc. Collaboration, Primary Investigators Andrew Berglund, Ph.D., University of Florida and Paul R. August, Ph.D., Vice President, Department Head -Discovery Biology, Icagen, Inc.: Inhibiting Transcription of CUG/CCUG Expanded Repeats with Small Molecules
  • The Critical Path Institute, Primary Investigator Jane Larkindale, DPhil.: Biomarker Qualification Project
  • University of Florida, Primary Investigator S.H. Subramony, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Iowa, Primary Investigator Laurie Gutmann, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Valencia, Primary Investigator Ruben Artero, Ph.D.: Support for publication and open access fee for a peer-reviewed Myotonic Dystrophy therapy paper

Fellowship Awards

  • Raphael Benhamou, Ph.D., Scripps Research Institute, Florida, U.S.: Targeting the RNA that Causes DM2 for Degradation with Small Molecules
  • Talita Conte, Ph.D., University of Montreal, Canada: Novel strategy targeting muscle stem cells as a therapeutic approach for myotonic dystrophy type 2
  • Jana Jenquin, Ph.D., University of Florida, U.S.: Improving the activity of diamidines for potential therapeutic use for patients with myotonic dystrophy types 1 and 2
  • Sarah Overby, University of Valencia, Spain: Restoration of MBNL proteins through miRNA blocking as DM1 therapy
  • Carl Shotwell, University of Florida, U.S.: Engineering Synthetic RNA Binding Proteins to Probe the Mechanisms of Myotonic Dystrophy and Development of Potential New Therapeutics
  • Shruti Choudhary, Ph.D., Scripps Research Institute Florida, U.S.: Selective and non-toxic small molecules that cleave r(CUG) repeats in DM1—optimization and evaluation as a therapeutic approach

More Information

Additional award information will be posted to this page as it becomes available. Click here to view a list of past grant recipients. For questions please contact:

Home / Grantees

© Myotonic. All rights reserved.